Effects of purified eicosapentaenoic acid versus mixed eicosapentaenoic/docosahexaenoic acid pharmacotherapies on coronary plaque volume: network meta-analysis of prospective coronary imaging trials

By afschroeder • August 13, 2025

Sheppard JP, Lakshmanan S, Palatnic L, Dahal S, Roy SK, Bhatt DL, Budoff MJ, Nelson JR. Effects of purified eicosapentaenoic acid versus mixed eicosapentaenoic/docosahexaenoic acid pharmacotherapies on coronary plaque volume: network meta-analysis of prospective coronary imaging trials. Acta Cardiol. 2025 Aug 12:1-13. doi: 10.1080/00015385.2025.2538404. Epub ahead of print. PMID: 40795199.

Tags: Cardiology/Epi, coronary artery disease, coronary imaging, docosahexaenoic acid, Eicosapentaenoic acid, Harbor UCLA, meta-analysis, Omega-3 fatty acids, Publications

Comparative effectiveness of sodium-glucose cotransporter 2 inhibitors along with colchicine versus colchicine alone among coronary artery disease and type 2 diabetes patients

Jaiswal V, Hanif M, Kumar D, Mashkoor Y, Kumar T, Ahmed R, Mattumpuram J, Qamar A, Fonarow GC, Lavie CJ. Comparative effectiveness of sodium-glucose cotransporter[...]

Transgenic mice overexpressing Pitx2 in the atria develop tachycardia-bradycardia syndrome

Baba S, Shinjo S, Seya D, Bochimoto H, Akaike T, Nakano A, Minamisawa S. Transgenic mice overexpressing Pitx2 in the atria develop tachycardia-bradycardia syndrome. PLoS[...]

Predicting risk of cardiovascular events (PREVENT) score accuracy among people with HIV in the multicenter CNICS cohort

Durstenfeld MS, Nance RM, Jones R, Abelman R, Hoffmann AP, Burkholder G, Hsue PY, Longenecker CT, Hunt PW, Saag MS, Delaney JAC, Feinstein MJ, Crane[...]